Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
about
Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-AnalysisThe potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoLow CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinomaPrognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma.Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts.Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors.Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX.Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody moleculeEndostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF-β1, HIF-1α and bFGF.CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastasesPrognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.Molecular markers for gastric adenocarcinoma: an update.Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma.Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer.Hypoxia in microscopic tumors.The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder.Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant.Carbonic anhydrase IX expression is associated with favorable prognostic factors in small intestinal carcinomaBiomarkers in Barrett's oesophagus and oesophageal adenocarcinoma.COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.NSAIDs inhibit tumorigenesis, but how?Generation of anti-tumour immune response using dendritic cells pulsed with carbonic anhydrase IX-Acinetobacter baumannii outer membrane protein A fusion proteins against renal cell carcinoma.Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53.Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniquesTyrosine kinase inhibitor sunitinib therapy is effective in the treatment of bone metastasis from cancer of unknown primary: Identification of clinical and immunohistochemical biomarkers predicting survival.In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesCarbonic Anhydrase XII as an Independent Prognostic Factor in Advanced Esophageal Squamous Cell Carcinoma.Effect of Targeted Therapy With Pazopanib on Expression Levels of Transcription, Growth Factors and Components of AKT/m-TOR Signaling Pathway in Patients with Renal Cell CarcinomaHypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts.
P2860
Q26749393-6E6CDCBC-BD1A-4DFD-AE1E-71AD760FAAD8Q26827175-7E4DD2AF-13B7-45FE-83FA-2128A506C80CQ27851432-331ECFCA-B122-41E7-AD67-972FE0ADD5FAQ30433038-F65E279D-2531-41D2-BBEC-1220671D035CQ30493513-DA0AFCC2-B57F-461A-BC59-363B0FCE0CF3Q33594289-834782F7-0B4B-4841-9DF7-E133C8999574Q33598505-13AB7773-1F69-4E4C-B67E-10093E769D44Q33871243-4D9E078D-0B93-4FBF-A0FA-2D463A3EEC40Q33932460-1E1AB1B8-3C9A-4123-98E4-4D0B783C490AQ33936624-758A87F1-E760-4D24-801D-020FEBCE9CA3Q34756174-B6D7827D-34B7-4D12-A8BD-BD87CABD2BDDQ34775811-E94A48D0-A311-447F-A6BB-34C2EB88231BQ35131660-F89737F3-0730-4892-863E-047DF1816552Q35145280-F6F7362F-0CE7-4809-9DA6-8B5CE2BD5B0DQ35148025-CDF4B92F-8BFA-4BEF-9A4E-0B3515E94BD8Q35202991-9851581E-B1D8-42C3-A1F7-228DD0AF1C89Q35451764-C11B3C69-DA96-4410-BBDC-3F98D3FF07A2Q35686653-BF504E39-FB3E-4442-891A-51D8C2DB798BQ36498885-9EEEB521-0B91-4BD5-B786-6DCE5CB8F5AFQ36677268-8FE47C52-DC70-4105-B6ED-42CEB8510D31Q36965105-D9234627-8A18-470B-A3C1-ADE362A891D7Q37083901-662C2B5C-40E5-4F34-BF4B-CEE4C52DC7E8Q37126963-B789ED4E-121D-418A-AB0E-6D5F0D91EC71Q37145181-CCE6CF1D-AF87-409F-96DA-C326AAC67AE0Q37177275-1F9A955C-8807-4F5A-9EC2-F0853177085EQ37604393-7FA45EB3-D750-4991-8862-94ED0D8CC242Q38089259-FA6EA6C8-A7F9-4DD3-8B83-02063DCA4493Q38123175-815A5517-52C3-4AD2-8139-741E92D4FF41Q38169133-9F7CAD8A-8FC6-4DBC-8259-B0F2FB0B107BQ38467824-EB6D7F1C-D9EB-4A7E-82CD-EA6296ED35D2Q38728290-FC51AECD-1E80-47EF-86A6-285A2498E201Q40445567-B0422B88-B605-4553-8AB6-B8BC193FB447Q40761584-0FB1B7D1-F1EF-44BD-9274-9089EF62A91EQ41395890-2574B2E2-7179-4411-8665-AEFB4FB295E6Q42713159-077EB3A4-4021-49D6-981F-6CC8E89AC7ADQ47367915-6C7963A0-FDFE-4859-A47B-CAB019E91087Q55046912-9A12D95A-8EF2-458E-A980-779B1236478C
P2860
Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Expression of carbonic anhydra ...... l and gastric adenocarcinomas.
@en
Expression of carbonic anhydra ...... l and gastric adenocarcinomas.
@nl
type
label
Expression of carbonic anhydra ...... l and gastric adenocarcinomas.
@en
Expression of carbonic anhydra ...... l and gastric adenocarcinomas.
@nl
prefLabel
Expression of carbonic anhydra ...... l and gastric adenocarcinomas.
@en
Expression of carbonic anhydra ...... l and gastric adenocarcinomas.
@nl
P2093
P2860
P1433
P1476
Expression of carbonic anhydra ...... l and gastric adenocarcinomas.
@en
P2093
Ann Driessen
Freddy Penninckx
Johnny Moons
Karel Geboes
Karin Haustermans
Laurence Goethals
Nadine Ectors
Philippe Nafteux
Sylvia Pastorekova
Toni Lerut
P2860
P304
P356
10.1097/01.SLA.0000201452.09591.F3
P407
P577
2006-03-01T00:00:00Z